Sinopharm

Biotech

Texas biotech’s COVID booster takes on competitors in phase 3

Vaxxinity’s next-gen COVID-19 booster candidate has hit its safety targets in a head-to-head phase 3 trial.
Gabrielle Masson Dec 2, 2022 11:00am

Sinopharm mulls $1B buy for DNA maker BBI Life Sciences: report

Jul 8, 2022 10:49am

Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up

Jan 15, 2021 9:05am

Chinese biotech Sinovac sees 78% COVID-19 vaccine efficacy

Jan 8, 2021 7:32am

China's Sinopharm sees 79% COVID-19 vaccine efficacy

Dec 30, 2020 9:25am

Sinopharm shares phase 2 data on inactivated COVID-19 vaccine

Aug 14, 2020 6:54am